99 related articles for article (PubMed ID: 12829732)
1. Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6).
Hines RN; Luo Z; Hopp KA; Cabacungan ET; Koukouritaki SB; McCarver DG
J Pharmacol Exp Ther; 2003 Sep; 306(3):1210-8. PubMed ID: 12829732
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the multifunctional transcription factor Yy1 and type 1 diabetes mellitus in the BB rat.
Klöting N; Klöting I
Mol Genet Metab; 2004 Jul; 82(3):255-9. PubMed ID: 15234341
[TBL] [Abstract][Full Text] [Related]
3. A functional SNP in the promoter region of TCOF1 is associated with reduced gene expression and YY1 DNA-protein interaction.
Masotti C; Armelin-Correa LM; Splendore A; Lin CJ; Barbosa A; Sogayar MC; Passos-Bueno MR
Gene; 2005 Oct; 359():44-52. PubMed ID: 16102917
[TBL] [Abstract][Full Text] [Related]
4. Regulation of flavin-containing monooxygenase 1 expression by ying yang 1 and hepatic nuclear factors 1 and 4.
Luo Z; Hines RN
Mol Pharmacol; 2001 Dec; 60(6):1421-30. PubMed ID: 11723251
[TBL] [Abstract][Full Text] [Related]
5. Expression of Pax2 in the intermediate mesoderm is regulated by YY1.
Patel SR; Dressler GR
Dev Biol; 2004 Mar; 267(2):505-16. PubMed ID: 15013809
[TBL] [Abstract][Full Text] [Related]
6. Increased incidence of FMO1 gene single nucleotide polymorphisms in sporadic amyotrophic lateral sclerosis.
Cereda C; Gabanti E; Corato M; de Silvestri A; Alimonti D; Cova E; Malaspina A; Ceroni M
Amyotroph Lateral Scler; 2006 Dec; 7(4):227-34. PubMed ID: 17127561
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants.
Koukouritaki SB; Poch MT; Cabacungan ET; McCarver DG; Hines RN
Mol Pharmacol; 2005 Aug; 68(2):383-92. PubMed ID: 15858076
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human collagen XVIII promoter 2: interaction of Sp1, Sp3 and YY1 with the regulatory region and a SNP that increases transcription in hepatocytes.
Armelin-Correa LM; Lin CJ; Barbosa A; Bagatini K; Winnischofer SM; Sogayar MC; Passos-Bueno MR
Matrix Biol; 2005 Dec; 24(8):550-9. PubMed ID: 16229994
[TBL] [Abstract][Full Text] [Related]
9. Displacement of YY1 by differentiation-specific transcription factor hSkn-1a activates the P(670) promoter of human papillomavirus type 16.
Kukimoto I; Kanda T
J Virol; 2001 Oct; 75(19):9302-11. PubMed ID: 11533193
[TBL] [Abstract][Full Text] [Related]
10. Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1).
Butcher NJ; Arulpragasam A; Pope C; Minchin RF
Biochem J; 2003 Dec; 376(Pt 2):441-8. PubMed ID: 12946272
[TBL] [Abstract][Full Text] [Related]
11. Structural characteristics of flavin-containing monooxygenase genes one and two (FMO1 and FMO2).
Wyatt MK; Philpot RM; Carver G; Lawton MP; Nikbakht KN
Drug Metab Dispos; 1996 Dec; 24(12):1320-7. PubMed ID: 8971137
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma.
Silverman ES; Palmer LJ; Subramaniam V; Hallock A; Mathew S; Vallone J; Faffe DS; Shikanai T; Raby BA; Weiss ST; Shore SA
Am J Respir Crit Care Med; 2004 Jan; 169(2):214-9. PubMed ID: 14597484
[TBL] [Abstract][Full Text] [Related]
13. Binding of serum response factor to cystic fibrosis transmembrane conductance regulator CArG-like elements, as a new potential CFTR transcriptional regulation pathway.
René C; Taulan M; Iral F; Doudement J; L'Honoré A; Gerbon C; Demaille J; Claustres M; Romey MC
Nucleic Acids Res; 2005; 33(16):5271-90. PubMed ID: 16170155
[TBL] [Abstract][Full Text] [Related]
14. Alternative processing events in human FMO genes.
Lattard V; Zhang J; Cashman JR
Mol Pharmacol; 2004 Jun; 65(6):1517-25. PubMed ID: 15155844
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the kappa casein (CSN3) gene in horse and comparative analysis of its promoter and coding region.
Hobor S; Kunej T; Dovc P
Anim Genet; 2008 Oct; 39(5):520-30. PubMed ID: 18752583
[TBL] [Abstract][Full Text] [Related]
16. A common promoter variant of TBX21 is associated with allele specific binding to Yin-Yang 1 and reduced gene expression.
Li JR; Li JG; Deng GH; Zhao WL; Dan YJ; Wang YM; Chen S
Scand J Immunol; 2011 May; 73(5):449-58. PubMed ID: 21272048
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
[TBL] [Abstract][Full Text] [Related]
18. Cloning and functional characterization of the rat alpha2B-adrenergic receptor gene promoter region: Evidence for binding sites for erythropoiesis-related transcription factors GATA1 and NF-E2.
Schaak S; Cussac D; Labialle S; Mignotte V; Paris H
Biochem Pharmacol; 2005 Aug; 70(4):606-17. PubMed ID: 15993847
[TBL] [Abstract][Full Text] [Related]
19. The -980C/G polymorphism in APH-1A promoter confers risk of Alzheimer's disease.
Qin W; Jia L; Zhou A; Zuo X; Cheng Z; Wang F; Shi F; Jia J
Aging Cell; 2011 Aug; 10(4):711-9. PubMed ID: 21443683
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
